Mpox severity and mortality in the DRC: a systematic review and meta-analysis (1970–2024)
11 affiliations
- 1Department of Public Health, Faculty of Medicine and Biomedical Sciences, The University of Yaounde I, Yaounde, Cameroon;
- 2MRCG at LSHTM, Banjul, The Gambia;
- 3Higher Institute of Medical Techniques, Bunia, Democratic Republic of Congo;
- 4Department of Public Health, Faculty of Medical Sciences, University of West Indies, Cave Hill, Barbados;
- 5Field Coordinator Frontline Field Epidemiology Training Program, Bangui, Central African Republic;
- 6Division of Health Policy and Research, Nkafu Policy Institute, Denis and Lenora Foretia Foundation, Yaounde, Cameroon;
- 7Division of Vaccination, Department of Family Health, Ministry of Public Health, Yaounde, Cameroon;
- 8Department of Family Health, Ministry of Public Health, Yaounde, Cameroon;
- 9Rosiere Higher School of Health Sciences, Yaounde, Cameroon;
- 10Public Health Operations Coordination Centre, Yaounde, Cameroon;
- 11Department of Mathematics, University of Manchester, Manchester, UK
Abstract
Background Mpox, caused by the Mpox virus, is a zoonotic disease historically endemic in Central and West Africa. Despite the Democratic Republic of Congo (DRC) carrying the highest Mpox burden, the literature lacks comprehensive data on long-term trends and geographic disparities inMpox% disease severity and mortality, highlighting a significant research gap. Understanding severity and mortality trends is critical for global control efforts. Methods This systematic review and meta-analysis followed PRISMA guidelines to synthesize evidence on Mpox severity and mortality in the DRC from 1970 to 2024. We searched PubMed, ScienceDirect, Scopus, Web of Science. Random-effects models addressed high heterogeneity, and subgroup analyses examined temporal trends, regional differences, and healthcare settings. Meta-regression explored sources of heterogeneity for both severity and case fatality rate, adjusting for study year, region, and setting. Results We included a total of 19 study reports. The pooled severity rate among 3,280 confirmed cases was 39.47% (95% confidence interval [CI] 29.11–50.86). Case fatality rates (CFRs) were 1.70% (95% CI 0.72–3.95) among 3152 suspected cases and 2.46% (95% CI 0.65–8.85) for 2239 confirmed cases. Meta-regression revealed that study year, region and setting were significant sources of heterogeneity of case fatality rates among confirmed mpox cases. Conclusion Mpox continues to impose a substantial burden in the DRC, with a high severity and moderate mortality rates. Targeted interventions, including vaccination in high-risk areas, community education, and healthcare system strengthening are warranted.
Related
- Machine learning for predicting mortality in patients with sepsis and its associated complications: A systematic review and meta-analysis
- Efficacy of Flavobacterium spp. Vaccines in fish: A systematic review and meta-analysis
- How Periodontal Disease Compromises Oral Functions Related to Ingestion: Evidence From Systematic Review and Meta‐Analysis
- Multiplex molecular respiratory diagnostic panels and antimicrobial use in paediatric respiratory infections: a systematic review and meta-analysis protocol.
- Effects of exercise on cognitive function in older adults: a systematic review and meta-analysis of the mediating role of sleep
BibTeX
@article{cheuyem2026mpox,
title = {{Mpox severity and mortality in the DRC: a systematic review and meta-analysis (1970–2024)}},
author = {Fabrice Zobel Lekeumo Cheuyem and Armel Zemsi and Jonathan Hangi Ndungo and Chabeja Achangwa and Davy Romeo Takpando-le-grand and Jessy Goupeyou-Youmsi and Solange Dabou and Mohamadou Adama and Ariane Nouko and Marie Angèle Mbang and Edwige Omona Guissana and Rick Tchamani and Vanessa Monique Mballa Assiene and Ethel Ambo Eno and Constantine Tanywe Asahngwa and Saralees Nadarajah},
journal = {Bulletin of the National Research Centre/Bulletin of the National Research Center},
year = {2026},
month = jul,
doi = {10.1186/s42269-026-01457-0},
url = {https://doi.org/10.1186/s42269-026-01457-0},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mpox severity and mortality in the DRC: a systematic review and meta-analysis (1970–2024)
AU - Fabrice Zobel Lekeumo Cheuyem
AU - Armel Zemsi
AU - Jonathan Hangi Ndungo
AU - Chabeja Achangwa
AU - Davy Romeo Takpando-le-grand
AU - Jessy Goupeyou-Youmsi
AU - Solange Dabou
AU - Mohamadou Adama
AU - Ariane Nouko
AU - Marie Angèle Mbang
AU - Edwige Omona Guissana
AU - Rick Tchamani
AU - Vanessa Monique Mballa Assiene
AU - Ethel Ambo Eno
AU - Constantine Tanywe Asahngwa
AU - Saralees Nadarajah
PY - 2026
DA - 2026/07/01
JO - Bulletin of the National Research Centre/Bulletin of the National Research Center
DO - 10.1186/s42269-026-01457-0
UR - https://doi.org/10.1186/s42269-026-01457-0
AB - Background Mpox, caused by the Mpox virus, is a zoonotic disease historically endemic in Central and West Africa. Despite the Democratic Republic of Congo (DRC) carrying the highest Mpox burden, the literature lacks comprehensive data on long-term trends and geographic disparities inMpox% disease severity and mortality, highlighting a significant research gap. Understanding severity and mortality trends is critical for global control efforts. Methods This systematic review and meta-analysis followed PRISMA guidelines to synthesize evidence on Mpox severity and mortality in the DRC from 1970 to 2024. We searched PubMed, ScienceDirect, Scopus, Web of Science. Random-effects models addressed high heterogeneity, and subgroup analyses examined temporal trends, regional differences, and healthcare settings. Meta-regression explored sources of heterogeneity for both severity and case fatality rate, adjusting for study year, region, and setting. Results We included a total of 19 study reports. The pooled severity rate among 3,280 confirmed cases was 39.47% (95% confidence interval [CI] 29.11–50.86). Case fatality rates (CFRs) were 1.70% (95% CI 0.72–3.95) among 3152 suspected cases and 2.46% (95% CI 0.65–8.85) for 2239 confirmed cases. Meta-regression revealed that study year, region and setting were significant sources of heterogeneity of case fatality rates among confirmed mpox cases. Conclusion Mpox continues to impose a substantial burden in the DRC, with a high severity and moderate mortality rates. Targeted interventions, including vaccination in high-risk areas, community education, and healthcare system strengthening are warranted.
SN - 1110-0591
SN - 2522-8307
ER -